U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937644) titled 'Effect of Clinical Pharmacist-Led Pharmaceutical Care in Major Depressive Disorder' on Nov. 09.
Brief Summary: This randomized controlled trial evaluated the effects of a six-month clinical pharmacist-led pharmaceutical care intervention on medication adherence, beliefs about medicines, and health-related quality of life in adults diagnosed with major depressive disorder (MDD) receiving antidepressant treatment.
A total of 186 participants were randomized in a 1:1 ratio to receive either structured pharmaceutical care in addition to usual psychiatric care or usual psychiatric care alone. Of these, 170 participants completed the six...